About US

About MediSieve

MediSieve spun-out from University College London in 2015 to develop and commercialise magnetic blood filtration. The company has raised a total of £2.1M in equity funding and won grants worth a total of over £2M from the Wellcome Trust, Innovate UK, NIHR i4i and the EU Horizon 2020 SME Instrument. With the ability to specifically and selectively remove disease causing agents from the blood, magnetic blood filtration has the potential to transform the treatment of blood borne diseases. The company’s initial targets include Sepsis, Leukaemia and Malaria. Located in the new Imperial College Translation and Innovation Hub in White City, the company is preparing for first in man trials in 2019.

Latest News

Laboratory Technician (Flow Cytometry) Position Open

Laboratory Technician (Flow Cytometry) Position Open
Created on 02-07-2019

MediSieve is looking for a highly motivated Flow cytometry Technician to join their team.  
MediSieve magnetic blood filter is granted US patent

MediSieve magnetic blood filter is granted US patent
Created on 13-06-2019

Medical device company MediSieve Ltd, which has developed the concept of magnetic blood filtration ...